Research reveals a therapeutic opportunity to prevent rhabdomyosarcoma recurrence

Rhabdomyosarcoma is a type of soft tissue cancer. Scientists at St. Jude Children's Research Hospital studied the population of cells that persists after therapy, causing rhabdomyosarcoma recurrence.

Related Keywords

Colorado ,United States ,California ,Irvine ,American ,Elizabeth Stewart ,Emily Henderson ,Xin Zhou ,Matthew Krasin ,Natalia Komorova ,Asa Karlstrom ,Michael Clay ,Anand Patel ,Michael Dyer ,Kaley Blankenship ,Xin Huang ,Dominik Wodarz ,Brent Orr ,Alberto Pappo ,Colleen Reilly ,Brittany Gordon ,Jiyang Yu ,Axiang Chen ,Jackie Norrie ,Heather Tillman ,Justina Mcevoy ,University Of California ,Solid Tumor Program ,National Pediatric Cancer Foundation ,Jude Children Research Hospital ,National Institutes Of Health ,Jude Childhood Solid Tumor Network ,American Association For Cancer Research ,University Of Colorado School Medicine ,Peterson Foundation ,Jude Department Of Oncology ,Tully Family Foundation ,Jude Department Of Developmental Neurobiology ,Jude Children ,Research Hospital ,Pediatric Cancer Genome Project ,Jude Department ,Developmental Neurobiology ,Developmental Biology ,Solid Tumor ,American Association ,Cancer Research ,Nextgen Stars ,Jude Cloud ,Colorado School ,National Institutes ,Lemonade Stand ,Hyundai Hope ,Damon Runyon Sohn Pediatric Cancer Fellowship ,Rhabdomyosarcoma ,Dancer ,Fell ,Chemotherapy ,Children ,Hospital ,Muscle ,Mh ,Research ,Na ,Tarcoma ,Soft Tissue Sarcoma ,Humor ,